Literature DB >> 1772127

Selegiline in the treatment of Parkinson's disease.

D W Robin1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1772127     DOI： 10.1097/00000441-199112000-00014

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN： 0002-9629            Impact factor:   2.378


× No keyword cloud information.
  1 in total

Review 1.  Selegiline: an appraisal of the basis of its pharmacoeconomic and quality-of-life benefits in Parkinson's disease.

Authors:  H M Bryson; R J Milne; P Chrisp
Journal:  Pharmacoeconomics       Date:  1992-08       Impact factor: 4.981
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.